feed,title,long_url,short_url
Benzinga,Why Analyst Says Rare Disease-Focused Inozyme Pharma Stock 'Could Be Worth A Look',https://benzinga.com/general/biotech/24/09/40841116/why-analyst-says-rare-disease-focused-inozyme-pharma-stock-could-be-worth-a-look,https://da.gd/HQIMRg
